Senior insider sale
Chief Medical Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$366.9K
76.41K shares
What this filing means
JAMIL KHURRAM plans to sell 76.41K shares of GALECTIN THERAPEUTICS INC valued at approximately $366.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001972481-26-000216
Officer· Chief Medical Officer
Since Aug 2024
76.41K
Shares to sell
$366.9K
Approx. market value
68.29K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
1/23/2025
16.25KStock Option Exercise
Cash
8/1/2024
50KStock Option Exercise
Cash
3/20/2024
2.04KTotal acquired68.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Stock Option Exercise Cash | 16.25K | — |
8/1/2024 | Stock Option Exercise Cash | 50K | — |
3/20/2024 | Stock Option Exercise Cash | 2.04K | — |
| Total | 68.29K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.56K
Market value
$23.7K
6/23/2026
—Completed
Units to sell
568.00
Market value
$1.8K
5/26/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
68.29K
Market value
$341.4K
6/26/2026
Total
Units
76.41K
Value
$366.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/23/2026 | 7.56K | $23.7K | — | Completed |
5/26/2026 | 568.00 | $1.8K | — | Completed |
| Planned — Approximate Date | ||||
6/26/2026 | 68.29K | $341.4K | Nasdaq | Planned |
| Total | 76.41K | $366.9K | ||